3D printing, a technology still in search of a market, may have just found a home in the world of medicine. The US Food and Drug Administration has approved an epilepsy medicine called Spritam that is made by 3D printers, making it the first 3D-printed product that the FDA has approved for use inside the human body. Aprecia, the pharmaceutical company behind Spritam, says that its new type of tablet is made by 3D-printing layers of the powdered drug, binding the layers of powder together, and then blowing away the excess powder. The drug’s unique structure allows it to dissolve considerably faster than the average pill, which as the news site 3DPrint points out is a boon to seizure sufferers who often are prescribed large, hard-to-swallow pills. 3D printing will allow doctors to know that the medicine they’re prescribing delivers the exact dose intended, as each pill will be completely uniform.